MEDITE Cancer Diagnostics, Inc. Announces Change of Auditor
PR Newswire - Thu May 14, 6:07PM CDT
MEDITE Cancer Diagnostics, Inc., ("Company," OTCQB symbol: "MDIT"
MEDITE Cancer Diagnostics, Inc. Reports 2014 Year End Results along with Expectations for 2015
PR Newswire - Mon May 11, 8:07AM CDT
MEDITE Cancer Diagnostics, Inc., (MDIT) specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces 2014 results and expectations for 2015.